Sunday 19 April 2026

Pharma & Biotech Start-up & Scale-up News

Featured

Ewopharma
A Vienna-based pharmaceutical company specializing in the commercialization and distribution of innovative medicines across Central and Eastern Europe, the Middle East, and North Africa.
Biotechnology
Biocytogen inks antibody deal with BeOne, expanding strategic ties
10 July 2025
article
IDEAYA exercises option for license on Biocytogen’s IDE034
11 November 2024

Latest Ones To Watch News

Biotechnology
UCB to acquire Neurona Therapeutics to advance epilepsy portfolio
18 April 2026
Biotechnology
Athernal Bio: targeting leukemia’s precursor – before the disease takes hold
17 April 2026
Pharmaceutical
Kailera Therapeutics announces $625 million IPO
17 April 2026
More ones to watch news >
Reset all filters
Refine search
Ewopharma
Ewopharma
Travere Therapeutics
Travere Therapeutics
OriCell Therapeutics
Annovis Bio
Cue Biopharma
Soleno Therapeutics
MoonLake Immunotherapeutics
Excellergy
Terns Pharmaceuticals
Karyopharm Therapeutics
Rhythm Pharmaceuticals
Ovid Therapeutics
Alto Neuroscience
Purple Biotech
BeOne Medicines
Medicus Pharma
Antengene
Priovant Therapeutics
Abcuro
Protara Therapeutics


Today's issue

The week in pharma: action, reaction and insight – week to April 17, 2026
Biotechnology
The week in pharma: action, reaction and insight – week to April 17, 2026
19 April 2026
Biotechnology
UCB to acquire Neurona Therapeutics to advance epilepsy portfolio
18 April 2026
Biotechnology
Athernal Bio: targeting leukemia’s precursor – before the disease takes hold
17 April 2026
Pharmaceutical
Grifols successfully completes refinancing
17 April 2026
Pharmaceutical
Kailera Therapeutics announces $625 million IPO
17 April 2026
Pharmaceutical
New leadership and financing for Achieve
17 April 2026
Biotechnology
EC approves Merck’s Enflonsia for RSV
17 April 2026


Company Spotlight

A Vienna-based pharmaceutical company specializing in the commercialization and distribution of innovative medicines across Central and Eastern Europe, the Middle East, and North Africa.




Copyright © The Pharma Letter 2026

 |  Headless Content Management with Blaze